Since implementation of our previous test update in June 2025, we have identified 6 new substances not previously detected in...
The goal of this clinical update is to review the prevalence of NPS detected at Aegis and trends in detection...
Our research shows that new and dangerous drugs continue to appear in the U.S. each year. In 2024 alone, 20...
Our research shows that new and dangerous drugs continue to appear in the U.S. each year. In 2024 alone, 20...
Medetomidine is a non-opioid veterinary anesthetic that acts as a synthetic agonist at alpha-2-adrenergic receptors. It belongs to the same...
To stay current with the rapidly changing landscape of new and emerging drugs, Aegis has committed to bi-annual NPS test...
Sign up for the Aegis Newsletter